Pricing Log in Create free account

Denali Therapeutics Inc. (DNLI) vs IDEAYA Biosciences, Inc. (IDYA)

Denali Therapeutics Inc. and IDEAYA Biosciences, Inc. are both Biotechnology companies. IDEAYA Biosciences, Inc. is the larger, with a market value of $3.3B against $2.9B — 1.1× the size. IDEAYA Biosciences, Inc. grew revenue faster over the last twelve months: 901.2% against 194.7%. IDEAYA Biosciences, Inc. has the higher net margin (−74.8% vs −171.1%) and the higher return on invested capital (−36.7% vs −260.5%). Across the 18 metrics below, IDEAYA Biosciences, Inc. leads on 15 and Denali Therapeutics Inc. on 3.

Valuation

Metric DNLI IDYA Biotechnology median
P/E n/m n/m 8.50
P/S 11.00 12.92 9.71
P/B 3.94 2.52 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.64 9.38 9.21
Earnings yield (16.17%) (5.84%) (33.15%)
Free cash flow yield (13.30%) (3.77%) (25.50%)

Profitability

Metric DNLI IDYA Biotechnology median
Gross margin 99.97% 100.00% 65.16%
Operating margin (181.51%) (92.66%) 0.00%
Net margin (171.06%) (74.75%) 0.00%
Free cash flow margin (146.31%) (48.64%) 0.00%
Return on equity (54.93%) (16.22%) (56.36%)
Return on assets (44.01%) (14.89%) (48.04%)
Return on invested capital (260.54%) (36.65%) 0.00%

Growth

Metric DNLI IDYA Biotechnology median
Revenue growth (TTM) 194.68% 901.18% 6.02%
EPS growth (last fiscal year) (15.56%) 61.90% 30.26%
Revenue growth, 5-year CAGR 20.67% 62.11% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNLI IDYA Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 8.37 10.45 4.72
Net debt to EBITDA 1.56 3.88 0.96

Dividend

Metric DNLI IDYA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DNLI IDYA Biotechnology median
Market cap 2.93b 3.27b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack